Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Plasma cell 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Lymphoma, T-Cell, Cutaneous 13Mycosis Fungoides 10Sezary Syndrome 9Lymphoma, Non-Hodgkin 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, Follicular 6Lymphoma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Uveal Melanoma 3Multiple Myeloma 3Melanoma 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell 3Lymphoma, Extranodal NK-T-Cell 3Leukemia, Hairy Cell 3Intraocular Lymphoma 3Subcutaneous panniculitis-like T-cell lymphoma 2Prostatic Neoplasms 2Neoplasms 2Leukemia, Myeloid, Acute 2

Interventions

pembrolizumab 16Cyclophosphamide 8Nivolumab 7Gemcitabine 6Paclitaxel 5Drug Therapy 5Docetaxel 5fludarabine 4aldesleukin 4Oxaliplatin 4Fluorouracil 4Carboplatin 4ulixertinib 3spartalizumab 3Trastuzumab 3Radiotherapy 3Leucovorin 3Capecitabine 3trametinib 2tovorafenib 2pertuzumab 2pegilodecakin 2pazopanib 2palbociclib 2osimertinib 2enzalutamide 2cemiplimab 2atezolizumab 2Taxes 2Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Vorinostat × Dermatologic × Clear all
NCT00667082 2017-11-22

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Celgene

Phase 1 Completed
22 enrolled
DermatologicGastrointestinalLymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Melanoma, Multiple Myeloma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡